From the AGA Journals
From the Journals
Childhood inflammatory bowel disease linked to increased mortality
The risk of death was three- to fivefold higher than that in the general population.
From the Journals
Metachronous advanced neoplasia linked to diminutive polyp number, not histology
Metachronous advanced neoplasia was diagnosed in similar proportions of patients with and without high-risk diminutive polyps.
From the Journals
Studies support vedolizumab-calcineurin inhibitor combinations but not accelerated infliximab therapy for refractory UC
Rates of colectomy were similar whether patients received induction immunotherapy with infliximab at weeks 0, 2, and 6, or on an accelerated...
From the Journals
Study supports swallowed topical steroids as maintenance for eosinophilic esophagitis
Rates of clinical remission were 16.1% and 1.3%, respectively (P less than .001).
From the Journals
Clinical Guidance: Thiopurine agents for the treatment of IBD
Thiopurines can reduce steroid use and increase anti–tumor necrosis factor blood values.
From the AGA Journals
Vedolizumab, tofacitinib induced rapid improvements in IBD symptoms
Two recent studies highlight the ability of vedolizumab and tofacitinib to rapidly improve symptoms reported by patients with inflammatory bowel...
From the Journals
Study eyed endoscopic submucosal dissection for early-stage esophageal cancer
Compared with esophagectomy, ESD was associated with significantly fewer severe adverse perioperative events and a similar rate of all-cause...
From the Journals
Vedolizumab, tofacitinib induced rapid improvements in IBD symptoms
Both biologics induced clinically meaningful improvements in patient-reported outcomes early in the course of treatment.
From the Journals
Routine markers predicted histologic response to obeticholic acid in NASH
Significant predictors included baseline nonalcoholic fatty liver disease activity score greater than 5, baseline triglycerides up to 154 mg/dL,...
From the Journals
Staying up to date on screening may cut risk of death from CRC
Staying up to date on screening was associated with a 62% decrease in the odds of dying from colorectal cancer.